ReviewInternational journal of molecular sciences2024

Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Wonyoung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.